They reported that the inhibition of LSD1 in human colon carcinoma cells by biguanide and bisguanidine polyamine analogues resulted in a re-expression of aberrantly silenced genes, including SFRP1, SFRP4, SFRP5, and GATA5 [28]. The gene discussed is SFRP4; the disease is colon carcinoma.